Your concierge doctor first visit labs are not a routine checkbox — they are the clinical foundation for every decision that follows, from dosing a GLP-1 to adjusting thyroid medication or starting hormone replacement therapy.

TL;DR: At a first visit, a concierge doctor typically orders a comprehensive metabolic panel, CBC, lipid panel, HbA1c, fasting insulin, TSH with free T3/T4, a full sex hormone panel (testosterone, estradiol, progesterone, DHEA-S, SHBG), vitamin D, and ferritin. That panel — 15 to 20 individual markers — gives the clinician a complete metabolic and hormonal baseline before any prescription is written. GoodLife Health uses this same protocol for every new member in 2026, with results reviewed by a licensed clinician before treatment begins.

Key Takeaways
  • Concierge first-visit panels cover 15-20 individual markers spanning metabolic, thyroid, hormonal, and micronutrient status.
  • 10-12 hours of fasting is required beforehand for accurate glucose, insulin, and lipid results.
  • A "normal" TSH or testosterone result can still leave a patient symptomatic — free T3/T4 and free testosterone/SHBG tell the fuller story.
  • Vitamin D deficiency shows up in 35-40% of adults presenting for metabolic care.
  • CBC is a required safety baseline before starting testosterone therapy or GLP-1 medications.
  • Results should be reviewed by a clinician in a dedicated conversation, not delivered as an unexplained portal notification.

Why the first-visit panel matters more than an annual physical

A standard insurance-based annual physical runs a basic metabolic panel and maybe a lipid screen. A concierge doctor runs a different kind of panel — one designed to catch the metabolic dysfunction and hormonal imbalance that standard care misses for years. The difference is not just test count; it is clinical intent. The labs are ordered to answer specific questions, not to satisfy billing codes.

In 2026, the most common reason adults join a direct primary care membership is that their previous doctor told them their labs were "normal" while they gained weight, felt exhausted, and lost libido. A thorough baseline panel almost always reveals why.

---

What you'll need before the draw

  • 10-12 hours of fasting before the blood draw. Water and plain black coffee are fine; cream, sugar, and food are not.
  • A complete medication and supplement list — some supplements (biotin, high-dose vitamin D) skew specific markers.
  • Any prior lab results you can share. Even a 2-year-old lipid panel helps the clinician spot a trend.
  • 20-30 minutes. The draw itself takes under 10 minutes. Lab turnaround at standard reference labs is 24-72 hours.

See the full pre-draw protocol in the what to eat before a fasting blood draw guide before your appointment.

---

The labs, step by step

Step 1 — Metabolic foundation (CMP + fasting insulin + HbA1c)

What it accomplishes: The comprehensive metabolic panel (CMP) reads kidney function (creatinine, BUN), liver enzymes (ALT, AST), electrolytes, and fasting glucose in a single draw. Adding HbA1c gives a 90-day glucose average, and fasting insulin reveals insulin resistance years before glucose goes abnormal.

Why it matters: A patient can have a fasting glucose of 94 mg/dL — technically normal — with a fasting insulin of 22 µIU/mL, indicating significant insulin resistance. That finding alone changes the conversation about whether a GLP-1 is indicated and which one to consider.

Clinical note

A patient can have a fasting glucose of 94 mg/dL — technically normal — with a fasting insulin of 22 µIU/mL, indicating significant insulin resistance. Glucose normalizes last; insulin dysregulation is the earlier signal, which is why skipping fasting insulin because the glucose looks fine is a common mistake.

Specific markers: Glucose, BUN, creatinine, eGFR, sodium, potassium, CO2, calcium, total protein, albumin, bilirubin, ALT, AST, alkaline phosphatase, HbA1c, fasting insulin.

Expected outcome: A fasting insulin above 10 µIU/mL in a fasting state is worth discussing. HbA1c above 5.7% signals pre-diabetes and makes the case for metabolic intervention.

Common mistake: Skipping the fasting insulin because the glucose looks fine. Glucose normalizes last — insulin dysregulation is the earlier signal.

---

Step 2 — Lipid panel (standard + advanced when indicated)

What it accomplishes: Total cholesterol, LDL, HDL, triglycerides, and the triglyceride-to-HDL ratio. A ratio above 3.0 is a practical proxy for insulin resistance and small-dense LDL particle dominance.

Why it matters: Triglycerides above 150 mg/dL combined with HDL below 40 mg/dL (men) or 50 mg/dL (women) in a fasting state is a metabolic syndrome marker. This panel shapes the diet and medication conversation immediately.

Common mistake: Reading only LDL in isolation. A patient with an LDL of 110 mg/dL and a triglyceride-to-HDL ratio of 4.5 carries more cardiovascular risk than the LDL alone suggests.

---

Step 3 — Thyroid panel (TSH + free T3 + free T4)

What it accomplishes: TSH alone is what most primary care offices run. A concierge doctor adds free T3 and free T4 to distinguish between a pituitary signal problem and a conversion problem. Some patients convert T4 to T3 poorly, a pattern TSH alone misses entirely.

Why it matters: Subclinical hypothyroidism — TSH between 2.5 and 4.5 mIU/L with symptoms — is one of the most under-treated causes of weight resistance, fatigue, and cognitive slowing in adults over 35.

Specific markers: TSH, free T3, free T4. Thyroid antibodies (TPO-Ab, TgAb) are added when autoimmune thyroid disease is suspected.

Common mistake: Treating a TSH of 3.8 as "normal" when the patient reports cold intolerance, constipation, and 20 lbs of unexplained weight gain. The reference range is population-based, not symptom-adjusted.

The thyroid and hormone imbalance guide covers the T3/T4 conversion issue in more detail.

---

Step 4 — Sex hormone panel

What it accomplishes: This is where a concierge first-visit panel diverges most sharply from standard care. The full sex hormone panel covers total testosterone, free testosterone, estradiol (E2), progesterone (day 21 of cycle for premenopausal women), DHEA-S, SHBG, and LH/FSH.

Why it matters for women: Low testosterone in women causes low libido, muscle loss, and mood instability — but it is almost never tested at a standard annual visit. SHBG determines how much testosterone is actually bioavailable; a woman with a "normal" total testosterone of 38 ng/dL but SHBG of 110 nmol/L has very little free testosterone in circulation.

Why it matters for men: Total testosterone reference ranges are broad (300–1000 ng/dL). A man at 310 ng/dL is technically in range but functionally low. Free testosterone and SHBG tell the complete story.

Common mistake: Drawing testosterone in the afternoon. Total testosterone follows a diurnal rhythm, peaking between 7–10 AM. An afternoon draw can read 15–20% lower than a morning draw for the same patient.

---

Step 5 — Micronutrients (vitamin D, ferritin, B12)

What it accomplishes: Vitamin D (25-OH), ferritin, and B12 are the three micronutrient markers most consistently correlated with fatigue, mood, and immune function in adults seeking care for metabolic or hormonal concerns.

Why it matters: Ferritin below 30 ng/mL produces fatigue and hair loss indistinguishable from thyroid or hormonal symptoms. Treating a ferritin of 12 ng/mL with hormone therapy will not resolve the fatigue. Vitamin D below 30 ng/mL impairs testosterone production, immune regulation, and insulin sensitivity.

Expected outcome: In 2026, population data from multiple outpatient labs consistently shows vitamin D deficiency in 35–40% of adults presenting for metabolic care. Supplementation protocols typically target a serum level of 50–70 ng/mL.

Common mistake: Running serum B12 and stopping there. Active B12 deficiency can exist with a serum B12 in the "normal" range (200–900 pg/mL). Methylmalonic acid is the confirmatory test when B12 deficiency is clinically suspected.

---

Step 6 — CBC with differential

What it accomplishes: Complete blood count reads red cell indices (hemoglobin, hematocrit, MCV), white cell differential, and platelet count. It establishes anemia type, screens for infection, and is a baseline requirement before starting testosterone therapy in men (hematocrit monitoring) or GLP-1 therapy.

Why it matters: Testosterone therapy raises hematocrit. A baseline above 50% before starting therapy is a clinical reason to delay or adjust dosing. You cannot know that without running the CBC.

Clinical note

Testosterone therapy raises hematocrit. A baseline above 50% before starting therapy is a clinical reason to delay or adjust dosing — the CBC is not optional, it informs safety monitoring for every common treatment in this space.

Common mistake: Skipping the CBC when the patient presents for "hormones only." The CBC is not optional — it informs safety monitoring for every common treatment in this space.

---

Step 7 — Inflammatory and metabolic extras (when indicated)

Depending on intake history, a clinician may add:

  • hsCRP — high-sensitivity C-reactive protein, a marker of systemic inflammation predictive of cardiovascular risk
  • Uric acid — elevated in metabolic syndrome and relevant when starting a GLP-1
  • PSA — prostate-specific antigen for men over 40 before starting testosterone
  • Cortisol (AM) — when symptoms suggest adrenal dysfunction or the patient is on chronic corticosteroids
  • Homocysteine — when cardiovascular risk is elevated or B-vitamin deficiency is suspected

Not every panel includes all of these. A good clinician adds them based on your history, not as a default upsell.

---

Troubleshooting: what to do when results come back

Common results and what to do about them

based on the troubleshooting scenarios below

Result you got backWhat to do
TSH is 3.2 mIU/L and you have symptomsDo not accept "that's normal" as a final answer — request free T3 and free T4 if they were not run.
Testosterone is "in range" but you feel lowAsk for SHBG and free testosterone; total testosterone alone leaves out bioavailable hormone.
Vitamin D came back at 22 ng/mLMost clinicians target 50-70 ng/mL and may prescribe 5,000 IU/day, with a recheck at 90 days.
Ferritin is below 30 ng/mLOral iron takes 3-4 months to meaningfully raise ferritin; IV iron is faster when symptoms are severe.
Results show pre-diabetes (HbA1c 5.7-6.4%)This is the inflection point where lifestyle intervention combined with GLP-1 therapy has the highest long-term impact.
You were told to fast but didn'tReschedule the draw — a non-fasted lipid panel is inaccurate.

Your TSH is 3.2 mIU/L and you have symptoms. Do not accept "that's normal" as a final answer. Request free T3 and free T4 if they were not run. Symptom context matters; the population reference range does not account for individual variation.

Your testosterone is "in range" but you feel low. Ask for SHBG and free testosterone. Total testosterone at 340 ng/dL with SHBG at 80 nmol/L leaves very little bioavailable hormone.

Your vitamin D came back at 22 ng/mL. Standard supplementation at 2,000 IU/day will raise levels slowly — most clinicians target 50–70 ng/mL and may prescribe 5,000 IU/day to get there faster, with a recheck at 90 days.

Your ferritin is below 30 ng/mL. Iron deficiency without anemia is real and under-treated. Oral iron supplementation takes 3–4 months to meaningfully raise ferritin. IV iron (Ferinject or Injectafer) is faster when symptoms are severe.

Results show pre-diabetes (HbA1c 5.7–6.4%). This is the clinical inflection point where lifestyle intervention combined with GLP-1 therapy has the highest long-term impact. The SURMOUNT-1 trial data (2022, n=2,539) showed tirzepatide reduced HbA1c by 2.1 percentage points in non-diabetic adults with obesity at 72 weeks.

You were told to fast but didn't. Reschedule the draw. A non-fasted lipid panel is inaccurate. Triglycerides in particular spike post-meal and will produce a misleading result.

---

Tools and resources

The numbers behind the panel
15-20
markers in a first-visit panel
18-25
total markers depending on intake history
35-40%
adults with vitamin D deficiency presenting for metabolic care
$179/mo
GoodLife Health membership, includes clinician lab review
$80-$150
direct-pay wholesale full panel vs $800+ retail
$12
direct-pay cost of a fasting insulin test in 2026

---

What to do next

If you have never had a full metabolic and hormonal panel, that is where to start. Book a first visit, confirm the panel includes all seven categories

References

  1. Direct Primary Care: Practice Distribution and Cost Across the Nation (J Am Board Fam Med). 2015. pubmed.ncbi.nlm.nih.gov/26546651/